Fact Check: Enron 'The Egg' home nuclear reactor is parody product
A parody product launch for a “micro nuclear reactor” for home use using the name of collapsed energy firm Enron Corp. has ...
Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking
The exposé led to the company’s CEO going to jail and to Anderson’s short-selling firm, Hindenburg Research, becoming one of ...
Our nation needs responsible corporate leaders
Responsible private sector leadership, with a true connection between business success and societal stability, is the best ...
CNET on MSN6d
Is the 'Enron Egg' At-Home Nuclear Reactor More Than a Funny Fake?
Something is stirring beneath the surface of a revived Enron, and it seems to be pushing a parody product of a stylish ...
Enron Egg was a joke. But Texas filings and a new executive may signal plans for a real business.
The new Enron has been dismissed by many as a joke or a publicity stunt, but recent filings and a newly-revealed executive ...
Can the Trump-Musk Marriage Be Saved? 3 Writers on an Inevitably Combustible Relationship.
Mr. Bruni is a contributing Opinion writer. Ms. McLean is a contributing editor at Vanity Fair and an author of “The Smartest ...
Fact Check: Boeing Starliner astronauts are alive contrary to misattributed Musk quote
The astronauts who traveled to the International Space Station aboard the Boeing Starliner are in good health, a NASA ...
How MicroStrategy’s Bitcoin strategy is attracting conservative investors
MicroStrategy's bitcoin-backed bonds attract conservative investors despite high risks. With shares surging and critics skeptical, is the bet sustainable?
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
January 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, ...
BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
It’s Time For Energy Regulation To Catch Up
There’s a saying that opportunity follows policy. This is especially true in highly regulated industries where regulation ...